From GlobeNewswire: 2025-06-05 09:15:00

Inspira Technologies has increased production of its FDA-cleared INSPIRA ART100 system in anticipation of demand from a European governmental authority. The ART100 system is gaining popularity in clinical settings for critical care and emergency preparedness programs. CEO Dagi Ben Noon stated that the company is preparing for commercial execution and expanding production capacity to meet deployment needs efficiently. This move follows the company’s global rollout strategy and commitment to revenue generation. Inspira Technologies aims to become a strategic public health supplier in governmental and private sectors with a focus on scalable respiratory solutions.



Read more at GlobeNewswire: Inspira Scales Up ART100 Production Capabilities Amid